A. Spanevello (Tradate, Italy), A. Ten Brinke (Leeuwarden, Netherlands), P. Pignatti (Pavia, Italy), P. Paggiaro (Pisa, Italy)
LATE-BREAKING ABSTRACT: A novel, simple and rapid method to measure soluble mediators in dithiothreitol-treated sputum
R. Milone, P. Chalk, K. Grace, D. Singh, R. Aul, R. Knowles (Stevenage, United Kingdom)
|   |
C-reactive protein levels in COPD according to clinical parameters, smoking behavior and pulmonary hypertension
F. Aksu, N. Capan, K. Aksu, R. Ofluoglu, S. Canbakan, K.O. Akin, B. Yavuz (Eskisehir, Ankara, Turkey)
| |
Serological detection of elastin fragments in COPD and IPF patients
F. Genovese, H. Skjøt-Arkil, R. Clausen, F.J. Martinez, C.M. Hogaboam, M. Han, M. Karsdal, D. Leeming (Herlev, Denmark)
| |
Laryngopharyngeal pepsin reflux in chest clinic patients with upper airways symptoms
A. Spyridoulias, S. Lillie, J. Haines, A. Vyas, S. Fowler (Preston, United Kingdom)
| |
Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease
Y. Cho, H. Kim, Y. Jeong, J. Lee, Y. Hwang (Jinju, Republic Of Korea)
| |
Correlation between sputum cytology and lung physiology in asthma and COPD subjects in Indian population
N. Iyer, R. Kodgule, M. Shaikh, S. Harangule, S. Madas, S. Salvi, B. Brashier (Pune, India)
| |
Validity of serum surfactant protein D as a lung-specific biomarker in monitoring asthma, chronic obstructive pulmonary disease and chronic bronchitis in Lebanese patients: Preliminary results
R. Jounblat, M. Waked, Z. Akiki, P. Salameh, H. Bouharoun-Tayoun, I. Tornøe, G.L. Sørensen, S. Chamat (Beirut, Lebanon; Odense, Denmark)
| |
Systemic inflammation in older adults with asthma-COPD overlap syndrome
J.J. Fu, V.M. McDonald, P.G. Gibson, J.L. Simpson (Newcastle, Australia)
| |
Repeatability and inter-relationships of small airway biomarkers in asthma
S. Gonem, S. Natarajan, S. Corkill, A. Singapuri, D. Desai, P. Gustafsson, C. Brightling, S. Siddiqui (Leicester, United Kingdom; Skövde, Sweden)
| |
Metabolic syndrome and chronic diseases in COPD
E. Bulcun, A. Ekici, M. Ekici (Kirikkale, Turkey)
| |
Microalbuminuria in chronic obstructive pulmonary disease
E. Bulcun, M. Ekici, A. Ekici (Kirikkale, Turkey)
| |
Chronic mucus hypersecretion in asthma: Relation to smoking status and disease severity
R. Chaudhuri, C. McSharry, M. Spears, N.C. Thomson (Glasgow, United Kingdom)
| |
The role of regional distribution (RD) of body fat mass (BFM) in fat-bone interactions in men with chronic obstructive pulmonary disease (COPD)
S. Lemiasheuskaya, A. Makarevich, A. Shepelkevich, N. Vasileva (Minsk, Belarus)
| |
The indices of body composition (IBC) consideration the changes of serum TNF-α, hormones and oxygen saturation (SO2%) in men with chronic obstructive pulmonary disease (COPD)
S. Lemiasheuskaya, A. Makarevich, N. Vasileva (Minsk, Belarus)
| |
Enzymatic activity and clinical parameters in non-cystic fibrosis bronchiectasis: A cohort analysis
P. Goeminne, J. Vandooren, A. Pauwels, A. Decraene, G. Opdenakker, L. Dupont (Leuven, Belgium)
| |
Asthma phenotyping: Correlation between inflammatory phenotype, clinical parameters and associated comorbidities
A. Van Den Bergh, S. Seys, P. Goeminne, L. Dupont, D. Bullens (Leuven, Belgium)
| |
Human neutrophil peptides as biotracers of functional impairment in COPD smokers
G. Paone, G. Schmid, V. Conti, F. Benassi, G. Giannunzio, G. Puglisi (Rome, Italy)
| |
Comparison between Penh and airway resistance in a mild and severe mouse model for allergic asthma
K. Verheijden, P. Henricks, F. Redegeld, F. Nijkamp, G. Folkerts (Utrecht, Netherlands)
| |